Division of Eye and Vision
The Division of Eye and Vision which is located at St. Erik Eye Hospital, conducts education at the undergraduate, advanced and postgraduate levels, as well as research with the aim of developing the eye care of the future.
Alcon USD 75,000 grant awarded to glaucoma researcher Pete Williams
Alcon USD 75,000 grant awarded to glaucoma researcher Pete Williams
Assistant Professor and Research Group Leader Pete Williams at St. Erik Eye Hospital and Karolinska Institutet has been appointed the 2021 Alcon Research Institute (ARI)
Shorter path to new treatments
Shorter path to new treatments
The research facilities in the new St. Erik Eye Hospital are now fully functional for researchers at St. Erik/Karolinska Institutet. The environment aims to provide optimal conditions for translating the research results faster and more efficiently from basic research to clinical reality for the patients.
New study on vitamin B₃ as a possible treatment for glaucoma
New study on vitamin B₃ as a possible treatment for glaucoma
Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on animal and cell models for glaucoma. The study, published in Redox Biology, may be a future neuroprotective therapy in glaucoma in humans. A clinical trial will start in the autumn.
Clinically transplantable photoreceptors researcher recruited thanks to philanthropic donation
Clinically transplantable photoreceptors researcher recruited thanks to philanthropic donation
A private philanthropic donation has made it possible for St. Erik Eye Hospital to finance the Karolinska Institutet appointment of stem cell researcher David Brenière-Letuffe.
Research groups
Physiological optics
Research group Brautaset
The field of physiological optics is wide and is related to the process of seeing, i.e., the optics of the eye, the physiological and psychological process of seeing, and the structure of the eye and visual system.
Glaucoma
Research group Pete Williams
Glaucoma is a complex, multifactorial disease affecting an estimated 80 million people worldwide and is the leading cause of irreversible blindness. It is a significant health and economic burden. Age, genetics, and high intraocular pressure (IOP) are all considerable risk factors.
Ocular Oncology and Pathology
Research group Stålhammar/Seregard
We perform translational research in clinical environments and laboratories. As both the affiliated researchers and the infrastructure are exclusively dedicated to ocular oncology and pathology, we aim to achieve and maintain excellence in this area.
Eye movements and vision
Research group Pansell
In Sweden and at Karolinska Institutet we have a long and proud tradition of vision research. The Sigvard and Marianne Bernadotte Research Laboratory for Pediatric Ophthalmology is the country's most advanced laboratory for research on children's eyes and vision.
Retina
Research group Kvanta/André
The research team is led by Professor Anders Kvanta and Dr Helder André, with a research portfolio to provide unpreceded cellular and molecular mechanistic views on neovascular and degenerative retinal diseases, with high focus on translational sustainable therapy strategies for patients with blinding diseases.
Cataract
Research group Löfgren
This research group consists of 19 specialists and two optometrists at St. Erik Eye Hospital. Research group leader is Stefan Löfgren. Group Cataract is not only conducting research about cataract but also about pediatric eye diseases and glaucoma.
New knowledge about hyaluronic acid may help patients with severe dry eye disease
New knowledge about hyaluronic acid may help patients with severe dry eye disease
High molecular weight hyaluronic eye drops 0.15 per cent, provided superior improvement of symptoms in patients with severe dry eye disease, when compared to other lubricant eye drops. This is the result of a clinical study from 2016–2020 published in the Journal of Clinical Medicine, coordinated by Ophthalmologist and Docent Gysbert van Setten at St. Erik Eye Hospital and Karolinska Institutet.
Not just a few tears
Not just a few tears
Only a few scientists devote their research to the problem with teary eyes. Oculoplastic Surgeon and researcher Elin Bohman is an exception. Her research has led to a new insight into how blocked tear ducts should be operated and new clues to the inner workings of the tear ducts.
Glaucoma researcher Pete Williams is awarded the Axel Hirsch Prize 2021
Glaucoma researcher Pete Williams is awarded the Axel Hirsch Prize 2021
Assistant Professor and Research Group Leader Pete Williams at Karolinska Institutet and St. Erik Eye Hospital receives the Axel Hirsch Prize 2021. He is awarded for his groundbreaking studies on glaucoma and the discovery that metabolic dysfunction casues mitochondrial abnormalities and neurodegeneration in patients with glaucoma.
Eye research expands when research group is split
Eye research expands when research group is split
Eye research at St. Erik Eye Hospital and Karolinska Institutet is advancing when the existing research group in retina and ocular oncology is divided into two to refine the research lines. Ophthalmologist and Associate Professor Gustav Stålhammar and researcher Helder André step in as new research group leaders.
He does research with the aim to reduce mortality from eye tumours
He does research with the aim to reduce mortality from eye tumours
Unlike most other types of cancer, the survival in ocular melanoma has not improved in several decades. This is something that eye specialist and researcher Gustav Stålhammar wants to change. "It is time we give this disease a fight. We need to investigate if it’s better to prevent the development of metastases rather than treating them once they appear", he says.